2023 Updated European Society of Cardiology guidelines on heart failure

Abstract

This article presents the new data of the 2023 European Society of Cardiology guidelines for the management of patients with acute and chronic heart failure, discussing key aspects, including their basic principles, recommendations for pharmacological and non-pharmacological treatment. In addition, their potential impact on the management of patients with heart failure was described.

Keywords

• chronic heart failure
• diuretics
• empagliflozin
• dapagliflozin